A detailed history of Lgt Group Foundation transactions in Abbott Laboratories stock. As of the latest transaction made, Lgt Group Foundation holds 4,718 shares of ABT stock, worth $625,842. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,718
Previous 4,953 4.74%
Holding current value
$625,842
Previous $564,000 5.5%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

SELL
$111.93 - $119.39 $26,303 - $28,056
-235 Reduced 4.74%
4,718 $533,000
Q3 2024

Nov 13, 2024

SELL
$100.07 - $118.13 $96,367 - $113,759
-963 Reduced 16.28%
4,953 $564,000
Q2 2024

Aug 07, 2024

BUY
$100.73 - $112.44 $210,324 - $234,774
2,088 Added 54.55%
5,916 $614,000
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $320,126 - $353,566
-2,923 Reduced 43.3%
3,828 $435,000
Q4 2023

Feb 06, 2024

BUY
$90.19 - $110.4 $3,607 - $4,416
40 Added 0.6%
6,751 $743,000
Q3 2023

Nov 06, 2023

BUY
$95.53 - $114.62 $203,287 - $243,911
2,128 Added 46.43%
6,711 $649,000
Q2 2023

Jul 27, 2023

SELL
$100.78 - $112.29 $205,188 - $228,622
-2,036 Reduced 30.76%
4,583 $499,000
Q1 2023

Apr 20, 2023

BUY
$96.86 - $114.01 $41,359 - $48,682
427 Added 6.9%
6,619 $670,000
Q4 2022

Feb 09, 2023

SELL
$95.06 - $111.52 $50,476 - $59,217
-531 Reduced 7.9%
6,192 $679,000
Q3 2022

Oct 19, 2022

BUY
$96.76 - $112.03 $161,782 - $187,314
1,672 Added 33.1%
6,723 $651,000
Q2 2022

Aug 03, 2022

SELL
$102.07 - $123.37 $1.02 Million - $1.24 Million
-10,015 Reduced 66.47%
5,051 $549,000
Q1 2022

May 11, 2022

SELL
$114.02 - $139.04 $293,829 - $358,306
-2,577 Reduced 14.61%
15,066 $1.79 Million
Q4 2021

May 03, 2022

BUY
$115.53 - $141.46 $2.04 Million - $2.5 Million
17,643 New
17,643 $2.48 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $232B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Lgt Group Foundation Portfolio

Follow Lgt Group Foundation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Group Foundation, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Group Foundation with notifications on news.